HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zheng Miao Selected Research

Cystine-Knot Miniproteins

11/2014A radiofluorinated divalent cystine knot peptide for tumor PET imaging.
4/2011Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy.
2/2011Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein.
11/2010PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide.
3/2010A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.
12/2009An engineered knottin peptide labeled with 18F for PET imaging of integrin expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zheng Miao Research Topics

Disease

36Neoplasms (Cancer)
09/2021 - 09/2009
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2017
5Melanoma (Melanoma, Malignant)
09/2013 - 10/2009
4Neoplasm Metastasis (Metastasis)
01/2020 - 10/2009
3Glioblastoma (Glioblastoma Multiforme)
02/2013 - 12/2009
2Rectal Neoplasms (Rectal Cancer)
01/2022 - 01/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019 - 06/2012
2Carcinoma (Carcinomatosis)
09/2013 - 06/2012
2Prostatic Neoplasms (Prostate Cancer)
09/2013 - 06/2012
2Breast Neoplasms (Breast Cancer)
07/2012 - 02/2012
1Adrenocortical Carcinoma
05/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020
1Endometrial Stromal Sarcoma
01/2020
1Pain (Aches)
08/2019
1Germinoma
03/2019
1Hypoxia (Hypoxemia)
11/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2018
1Hemorrhagic Fever with Renal Syndrome (HFRS)
10/2018
1Neuroinflammatory Diseases
01/2018
1Disease Progression
01/2018
1Huntington Disease (Huntington's Disease)
01/2018
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2016
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2014
1Stroke (Strokes)
12/2014
1Ovarian Neoplasms (Ovarian Cancer)
11/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2013
1Adenocarcinoma
07/2013
1Glioma (Gliomas)
04/2011

Drug/Important Bio-Agent (IBA)

15Peptides (Polypeptides)IBA
11/2014 - 11/2009
11IntegrinsIBA
11/2014 - 12/2009
7Proteins (Proteins, Gene)FDA Link
07/2012 - 09/2009
7ErbB Receptors (EGF Receptor)IBA
07/2012 - 05/2010
6Cystine-Knot MiniproteinsIBA
11/2014 - 12/2009
6Molecular Probes (Molecular Probe)IBA
09/2013 - 09/2009
61,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
07/2012 - 03/2010
4Biomarkers (Surrogate Marker)IBA
01/2018 - 09/2009
4Cystine (L-Cystine)IBA
11/2014 - 02/2010
3Coloring Agents (Dyes)IBA
11/2014 - 05/2010
3MetalsIBA
11/2014 - 11/2009
3Agouti-Related ProteinIBA
02/2013 - 02/2010
3Radioisotopes (Radionuclides)IBA
07/2012 - 04/2011
3CY5.5 cyanine dyeIBA
06/2012 - 03/2010
3PeptidomimeticsIBA
01/2012 - 12/2009
2RadiopharmaceuticalsIBA
01/2016 - 06/2012
2Chelating AgentsIBA
11/2014 - 06/2011
2Melanins (Melanin)IBA
09/2013 - 10/2009
2BombesinIBA
09/2013 - 06/2012
2Bombesin Receptors (Bombesin Receptor)IBA
09/2013 - 06/2012
2Indicators and Reagents (Reagents)IBA
11/2011 - 05/2010
2RheniumIBA
12/2010 - 11/2009
2Trypsin InhibitorsIBA
03/2010 - 12/2009
1Phosphotransferases (Kinase)IBA
09/2021
1squamous cell carcinoma-related antigenIBA
11/2019
1EtanidazoleIBA
11/2018
1carbogenIBA
11/2018
1NitroimidazolesIBA
11/2018
1dechlorane plusIBA
10/2018
1Flame Retardants (Fire Retardants)IBA
10/2018
1Halogenated Diphenyl EthersIBA
10/2018
1LigandsIBA
01/2018
1LM11A-31IBA
01/2018
1acetamideIBA
01/2015
1Minocycline (Cyclops)FDA LinkGeneric
12/2014
1Dendrimers (Dendrons)IBA
11/2014
14-nitrophenylIBA
11/2014
1N,N-diethylethylenediamineIBA
09/2013
1benzamideIBA
09/2013
1Niacinamide (Nicotinamide)FDA LinkGeneric
09/2013
1pyridineIBA
09/2013
1Benzene (Benzole)IBA
09/2013
1arginyl-glycyl-aspartic acidIBA
09/2013
1Cell Surface ReceptorsIBA
07/2013
1picolinamideIBA
02/2013
1polypeptide CIBA
02/2013
1Cys-ZHER2-342 affibodyIBA
07/2012
1Fluorescent Dyes (Fluorescent Probes)IBA
06/2012
1Ethylene Glycol (Monoethylene Glycol)IBA
06/2012
1Tumor Biomarkers (Tumor Markers)IBA
06/2012
1Pharmaceutical PreparationsIBA
06/2012
11,4,7,10- tetraazacyclododecane- 1,4,7- triacetic acidIBA
06/2012
1Human Serum AlbuminFDA LinkGeneric
06/2012
117- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
02/2012
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2012
1CytokinesIBA
11/2011
1EnzymesIBA
11/2011

Therapy/Procedure

12Radiotherapy
01/2022 - 01/2015
10Therapeutics
01/2022 - 09/2009
3Drug Therapy (Chemotherapy)
01/2022 - 11/2017
3Brachytherapy
01/2021 - 11/2017
3Chemoradiotherapy
12/2019 - 11/2018
2Neoadjuvant Therapy
01/2022 - 01/2020
2Adjuvant Radiotherapy
05/2020 - 01/2020
2Aftercare (After-Treatment)
11/2018 - 01/2015
1Adjuvant Chemotherapy
01/2022
1Surgical Instruments (Clip)
01/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020
1Craniospinal Irradiation
03/2019
1Duration of Therapy
11/2018
1Oral Administration
01/2018
1Endoscopes
08/2011